Gsk (GLAXF) EBT Margin (2009 - 2026)

Gsk (GLAXF) recorded quarterly EBT Margin of 28.1% in Q1 2026, up 154.94% quarter-over-quarter from 11.02% in Q4 2025, and up 6.0% on a YoY basis from 26.51% in Q1 2025.

Gsk (GLAXF) EBT Margin (2009 - 2026) Analysis & Trends

Gsk's EBT Margin history runs 18 years deep, the most recent figure standing at 28.1% for Q1 2026.

  • In Q1 2026, EBT Margin rose 6.0% year-over-year to 28.1%; the TTM figure through Mar 2026 stood at 22.73% (up 596.0% YoY), while the FY2025 annual figure was 22.66%, up 1157.0% from the prior year.
  • EBT Margin was 28.1% for Q1 2026 at Gsk, up from 11.02% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 29.12% in Q1 2022 to a low of 0.8% in Q3 2024.
  • Historically, EBT Margin has averaged 21.01% across 5 years, with a median of 21.98% in 2023.
  • The sharpest annual moves came in 2022 and 2025: EBT Margin sank 2968 bps in 2022, then soared 2794 bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 21.18% in 2022, then surged by 30 bps to 27.56% in 2023, then sank by 32 bps to 18.69% in 2024, then plunged by 41 bps to 11.02% in 2025, then soared by 155 bps to 28.1% in 2026.
  • The last three EBT Margin figures came in at 28.1% (Q1 2026), 11.02% (Q4 2025), and 28.74% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 28.10%
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 44.70%
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 24.89%
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 6.93%
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -21.49%
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 24.18%
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 37.07%
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 135.53%
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 28.20%
10 Gsk - - 7.76 Bn 28.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 28.10%
Dec 31, 2025 11.02%
Sep 30, 2025 28.74%
Jun 30, 2025 23.63%
Mar 31, 2025 28.05%
Dec 31, 2024 18.69%
Sep 30, 2024 0.80%
Jun 30, 2024 18.96%
Mar 31, 2024 18.40%
Dec 31, 2023 27.56%
Sep 30, 2023 21.98%
Jun 30, 2023 27.68%
Mar 31, 2023 27.43%
Dec 31, 2022 21.18%
Sep 30, 2022 12.93%
Jun 30, 2022 12.93%
Mar 31, 2022 29.12%
Dec 31, 2021 50.86%
Sep 30, 2021 17.99%
Jun 30, 2021 18.33%